Revolutionary UV-C Device Offers Hope in the Fight Against Central Line-associated Bloodstream Infections (CLABSIs)
A recent study’s results demonstrate that PuraCath Medical Inc.'s breakthrough UV-C device disinfects needleless connectors, potentially reducing CLABSI risks in hospital settings.
United States Puracath Medical Inc Us Department Of Health Centers For Medicare Medicaid Services Human Services Adobe Stock
Source: infectioncontroltoday.com